Vice President, Medical
1 month ago
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ® molecules, for diseases that are underserved by existing therapeutics. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. and BT7480, a Bicycle Tumor-Targeted Immune Cell Agonist ® (Bicycle TICA ®) targeting Nectin-4 and agonizing CD137, in company-sponsored clinical trials. Additionally, the company is developing Bicycle ® Radio Conjugates (BRC™) for radiopharmaceutical use and, through various partnerships, is exploring the use of Bicycle ® technology to develop therapies for diseases beyond oncology. Bicycle Therapeutics is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Cambridge, MA.
Bicycle Therapeutics is seeking a motivated physician leader with oncology drug development experience to serve as Vice President Clinical Development, based in either Cambridge, UK or Cambridge, MA. This leadership role sits within a growing clinical development organization in the oncology space involving several highly novel Bicycle® (bicyclic peptide) therapeutics, designed from our proprietary platform. You will report to the Chief Development Officer and directly influence the development of novel molecules of our portfolio in oncology and help to define the broader clinical development strategy. You will collaborate internally with clinical, translational and scientific groups.
You will be responsible for study conduct, program activities and clinical development plans across the portfolio.
The ideal candidate will have deep expertise in early to late-stage clinical development and a demonstrable track record of advancing precision medicines from bench to bedside to approval with strong scientific rigor and a thorough understanding of target and disease biology.
As a key member of the Development Leadership Team, you will be responsible for providing scientific, clinical and product development leadership and support for development programs across the Bicycle portfolio.
Provide indirect leadership to a cross-functional, matrix team of physicians, clinical scientists and other development teams
Responsible for the generation and continual refinement of the clinical development plans for Bicycle’s portfolio from IND to POC to NDA
Provide key contribution to IND, NDA, PMA submissions via overseeing medical documentation and active participation in meetings with regulatory agencies
Clinical lead for early development study conduct including study design, protocol writing, regulatory documents, CRO interactions, study start up, investigator interactions, data monitoring, health authority interactions, analyses and study reports.
Establish and develop relationships with investigators, thought leaders, in close collaboration with the Medical Affairs function
Assist in scientific advisory boards, conference activities, external collaborations and partnerships
Provide medical, disease-specific, and development perspective into specific research programs or broader research initiatives
Medical Doctor (MD/MBBS/DO) degree
Ideally a medical oncologist, or possess a deep knowledge and understanding of oncology, including companion diagnostics, precision oncology drug development paradigms, clinical pharmacology and technical, business, and regulatory approaches
In depth understanding of phase I-IV drug development
You are passionate about clinical development and precision, and are well connected to external experts and highly credible advisors in the oncology space
You have talent and ability in forging and nurturing key partnerships and collaborations with the external scientific community, including academia, governmental organizations, nonprofit organizations and CROs
State-of-the-art campus environment with on campus restaurant and Montessori nursery
~ Flexible working environment
~ Competitive reward including annual company bonus
~ Employee recognition schemes
~28 days annual leave in addition to bank holidays+ option to buy up to 5 additional days annually
~ Employer contribution to pension (employee does not have to contribute)
~ Life assurance cover 4x basic salary
~ Private Medical Insurance, including optical and dental cover.
~ Employee assistance program
~ Health Cash Plan
~ Access to company subsidized gym membership.
~ Eligibility for an option grant to subscribe to shares in Bicycle Therapeutics plc.
~ Cycle to work scheme
Bicycle Therapeutics is committed to building a diverse workforce that is representative of the communities we serve. Therefore, all qualified applicants will be considered for employment, and we do not discriminate on the basis of race, religion, colour, gender, sexual orientation, age, disability status, marital status, or veteran status.
-
Vice President, Clinical Development
4 weeks ago
Abington Pigotts, Cambridgeshire, United Kingdom Bicycle Therapeutics Full timeVice President, Clinical Development (MD) 1 week ago Be among the first 25 applicants Direct message the job poster from Bicycle Therapeutics Senior Talent Acquisition Partner @ Bicycle Therapeutics | Full-life Cycle Recruiting Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ...
-
Vice President, Clinical Development
4 weeks ago
Abington Pigotts, Cambridgeshire, United Kingdom Bicycle Therapeutics Full timeVice President, Clinical Development (MD) 1 week ago Be among the first 25 applicants Direct message the job poster from Bicycle Therapeutics Senior Talent Acquisition Partner @ Bicycle Therapeutics | Full-life Cycle Recruiting Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ...
-
Vice President, Clinical Development
1 week ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeJob DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural...
-
Vice President, Clinical Development
1 month ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ®molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
1 month ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
1 month ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
4 weeks ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
4 weeks ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
1 month ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
3 weeks ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
3 weeks ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
1 month ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
1 month ago
Abington Pigotts, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Medical
3 weeks ago
Cambridge, Cambridgeshire, United Kingdom Bicycle Therapeutics Full timeVice President, Clinical Development (MD) ~ Full-time ~ Contract type: Permanent Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. This constraint facilitates target binding with high affinity and...
-
Vice President, Medical
3 weeks ago
Cambridge, Cambridgeshire, United Kingdom Bicycle Therapeutics Full timeVice President, Clinical Development (MD) ~ Full-time ~ Contract type: Permanent Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. This constraint facilitates target binding with high affinity and...
-
Vice President, Clinical Development
1 month ago
Abington Pigotts, Cambridgeshire, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
1 month ago
Abington Pigotts, Cambridgeshire, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
4 weeks ago
Abington Pigotts, Cambridgeshire, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry....
-
Vice President, Clinical Development
4 weeks ago
Abington Pigotts, England, United Kingdom Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ®Find out more about this role by reading the information below, then apply to be considered.molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained...
-
Development Lead
3 weeks ago
Great Abington, Cambridgeshire, United Kingdom ISTITUTO MARANGONI Full timeCompany Description Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug...
